Convolutional neural network-based risk score

1. Cholecalciferol has no effect on convolutional neural network-based risk score in humans (0.005 vs 0.002, P = .875 at 12 months; 0.020 vs 0.001, P = .563 at 24 months).

   “Change in convolutional neural network-based risk score was not statistically significantly different between vitamin D and placebo groups at 12 months (0.005 vs 0.002, P = .875) or at 24 months”

   Human trialhigh-risk premenopausal womenoralbreast20 000 IU weekly12 monthsfemalesn = 208

   Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812

   JNCI cancer spectrum·Jul 1, 2024

More on Cholecalciferol